ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 754,99
0,41%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Natera Inc (NTRA)

  7. Natera Inc (NTRA) Actualités

NTRA

Natera (NTRA)

Natera Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTRA
DateHeureSourceTitreSymboleSociété
01/06/202403h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NTRANatera Inc
31/05/202400h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NTRANatera Inc
30/05/202414h00Business WireNatera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024NASDAQ:NTRANatera Inc
23/05/202422h05Business WireNatera to Present at the 2024 Leerink Partners Healthcare Crossroads ConferenceNASDAQ:NTRANatera Inc
23/05/202413h30Business WireNatera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual MeetingNASDAQ:NTRANatera Inc
09/05/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NTRANatera Inc
09/05/202422h05Business WireNatera Reports First Quarter 2024 Financial ResultsNASDAQ:NTRANatera Inc
03/05/202414h00Business WireNew Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast CancerNASDAQ:NTRANatera Inc
01/05/202422h05Business WireNatera to Report its First Quarter 2024 Results on May 9NASDAQ:NTRANatera Inc
01/05/202413h00Business WireNatera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg ShortageNASDAQ:NTRANatera Inc
22/04/202414h00Business WireNatera Announces Significant Milestone with 200+ Peer-Reviewed PublicationsNASDAQ:NTRANatera Inc
11/04/202414h00Business WireNatera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney TransplantationNASDAQ:NTRANatera Inc
08/04/202414h00Business WireNatera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant RecipientsNASDAQ:NTRANatera Inc
05/04/202413h00Business WireNatera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder CancerNASDAQ:NTRANatera Inc
01/04/202414h00Business WireNatera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial CancerNASDAQ:NTRANatera Inc
18/03/202412h00Business WireNatera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal CancerNASDAQ:NTRANatera Inc
14/03/202413h00Business WireNew KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of DiseaseNASDAQ:NTRANatera Inc
12/03/202413h00Business WireNatera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast CancersNASDAQ:NTRANatera Inc
07/03/202414h00Business WireNatera Announces Commercial Coverage for Prospera™ Kidney and Prospera Heart™ from a Top BCBS PlanNASDAQ:NTRANatera Inc
29/02/202414h00Business WireNatera to Participate in March Investor ConferencesNASDAQ:NTRANatera Inc
28/02/202422h05Business WireNatera Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NTRANatera Inc
27/02/202414h00Business WireNatera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure TestsNASDAQ:NTRANatera Inc
26/02/202413h00Business WireMedicare Extends Coverage of Natera’s Signatera™ MRD Test to Ovarian Cancer and Neoadjuvant Breast CancerNASDAQ:NTRANatera Inc
20/02/202414h00Business WireNatera Announces Fourth Quarter and Fiscal 2023 Earnings Conference CallNASDAQ:NTRANatera Inc
05/02/202414h00Business WireNew Study Validates Signatera™ in Endometrial CancerNASDAQ:NTRANatera Inc
31/01/202403h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NTRANatera Inc
30/01/202413h00Business WireNew Publication Demonstrates Signatera’s Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung CancerNASDAQ:NTRANatera Inc
29/01/202413h00Business WireJury Rules in Favor of Natera in Patent Infringement Lawsuit Against CareDx; Awards $96.3 Million in Damages to Natera in Lost Profits and Past RoyaltiesNASDAQ:NTRANatera Inc
25/01/202413h00Business WireNature Medicine Publishes Two Studies Highlighting Signatera’s Clinical Utility in Patients with Gastrointestinal MalignanciesNASDAQ:NTRANatera Inc
22/01/202413h00Business WireNatera Acquires Reproductive Health Assets from InvitaeNASDAQ:NTRANatera Inc
 Showing the most relevant articles for your search:NASDAQ:NTRA

Dernières Valeurs Consultées

BIT
S29048
Societe Generale Effekten
COIN
PCOINETH
LBNK
WOOUSDT
WOO Network (Wootrade Network)
BIT
P1OBA0
BNP Paribas Issuance
BIT
UC16ZK
Unicredit Bank
USOTC
RSAWS
RSE Archive (GM)
LBNK
DNXUSDT
Dynex
BIT
UB9C35
Unicredit Bank
LSE
46IO
Barclays 24
EU
FR001400NXC0
Agence France Locale Afl...
NASDAQ
SNAXW
Stryve Foods
BIT
UC6M11
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés